We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
RE/MAX Holdings
RMAX
$200M
| $14.2K | ﹤0.01% |
1,436
-753
| -34% | -$6.57K |
|
2102
Celsius Holdings
CELH
$6.93B
| $14.1K | ﹤0.01% |
483
-460
| -49% | -$14.5K |
|
2103
Hingham Institution for Saving
HIFS
$614M
| $14.1K | ﹤0.01% |
46
+4
| +10% | +$1.15K |
|
2104
Cal-Maine
CALM
$4.28B
| $14.1K | ﹤0.01% |
175
-38
| -18% | -$2.93K |
|
|
TE
2105
T1 Energy
TE
$1.4B
| $14.1K | ﹤0.01% |
+1,487
| New | +$10.6K |
|
2106
BioLife Solutions
BLFS
$1.46B
| $14.1K | ﹤0.01% |
498
+42
| +9% | +$982 |
|
|
PPTA
2107
Perpetua Resources
PPTA
$2.23B
| $14.1K | ﹤0.01% |
677
+103
| +18% | +$2.79K |
|
2108
Red River Bancshares
RRBI
$655M
| $14K | ﹤0.01% |
153
| – | – |
|
2109
Kura Oncology
KURA
$922M
| $14K | ﹤0.01% |
1,272
| – | – |
|
2110
Mineralys Therapeutics
MLYS
$2.35B
| $13.8K | ﹤0.01% |
513
| – | – |
|
2111
Pan American Silver
PAAS
$18.6B
| $13.8K | ﹤0.01% |
309
-315
| -50% | -$16.9K |
|
2112
Mesa Laboratories
MLAB
$539M
| $13.8K | ﹤0.01% |
139
+9
| +7% | +$906 |
|
2113
Metropolitan Bank Holding Corp
MCB
$1.13B
| $13.8K | ﹤0.01% |
140
| – | – |
|
2114
RBB Bancorp
RBB
$446M
| $13.8K | ﹤0.01% |
504
| – | – |
|
2115
Donnelley Financial Solutions
DFIN
$1.21B
| $13.8K | ﹤0.01% |
329
-659
| -67% | -$28.7K |
|
2116
Ennis
EBF
$546M
| $13.8K | ﹤0.01% |
649
| – | – |
|
2117
BellRing Brands
BRBR
$1.51B
| $13.8K | ﹤0.01% |
1,065
+151
| +17% | +$1.82K |
|
|
MPT
2118
Medical Properties Trust
MPT
$2.89B
| $13.8K | ﹤0.01% |
2,982
-442
| -13% | -$2.19K |
|
2119
Core Scientific
CORZ
$7.23B
| $13.8K | ﹤0.01% |
538
-3,138
| -85% | -$73.9K |
|
|
LADR
2120
Ladder Capital
LADR
$1.25B
| $13.7K | ﹤0.01% |
1,375
+1,243
| +942% | +$12.6K |
|
2121
Navitas Semiconductor
NVTS
$2.66B
| $13.6K | ﹤0.01% |
760
+610
| +407% | +$11.6K |
|
2122
Universal Display
OLED
$3.71B
| $13.6K | ﹤0.01% |
157
+74
| +89% | +$6.83K |
|
2123
Newmark Group
NMRK
$2.73B
| $13.4K | ﹤0.01% |
890
+122
| +16% | +$1.86K |
|
2124
Atkore
ATKR
$2.59B
| $13.4K | ﹤0.01% |
176
-39
| -18% | -$2.94K |
|
2125
Clear Secure
YOU
$5.26B
| $13.4K | ﹤0.01% |
240
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.